BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

P. Murali Doraiswamy

P. Murali Doraiswamy contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
cs.CYNeurons and Cognition

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

Digital Therapeutics for Mental Health: Is Attrition the Achilles Heel?

Digit therapeutics are novel software devices that clinicians may utilize in delivering quality mental health care and ensuring positive outcomes. However, uptake of digital therapeutics and clinically tested software-based programs remains low. This article presents possible reasons for attrition and low engagement in clinical studies investigating digital therapeutics, analyses of studies in which engagement was high, and design constructs that may encourage user engagement. The aim is to shed light on the importance of real-world attrition data of digital therapeutics, and important characteristics of medical devices that have positively influenced user engagement. The findings presented in this article will be useful to relevant stakeholders and medical device experts tasked with addressing the gap between software medical design and user engagement present in digital therapeutic clinical trials.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Validity of Web-based, Self-directed, NeuroCognitive Performance Test in MCI

Digital cognitive tests offer several potential advantages over established paper-pencil tests but have not yet been fully evaluated for the clinical evaluation of mild cognitive impairment. The NeuroCognitive Performance Test (NCPT) is a web-based, self-directed, modular battery intended for repeated assessments of multiple cognitive domains. Our objective was to examine its relationship with the ADAS-Cog and MMSE as well as with established paper-pencil tests of cognition and daily functioning in MCI. We used Spearman correlations, regressions and principal components analysis followed by a factor analysis (varimax rotated) to examine our objectives. In MCI subjects, the NCPT composite is significantly correlated with both a composite measure of established tests (r=0.78, p<0.0001) as well as with the ADAS-Cog (r=0.55, p<0.0001). Both NCPT and paper-pencil test batteries had a similar factor structure that included a large g component with a high eigenvalue. The correlation for the analogous tests (e.g. Trails A and B, learning memory tests) were significant (p<0.0001). Further, both the NCPT and established tests significantly (p< 0.01) predicted the University of California San Diego Performance-Based Skills Assessment and Functional Activities Questionnaire, measures of daily functioning. The NCPT, a web-based, self-directed, computerized test, shows high concurrent validity with established tests and hence offers promise for use as a research or clinical tool in MCI. Despite limitations such as a relatively small sample, absence of control group and cross-sectional nature, these findings are consistent with the growing literature on the promise of self-directed, web-based cognitive assessments for MCI.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Advancing computerized cognitive training for early Alzheimer&#39;s disease in a Covid-19 pandemic and post-pandemic world

The COVID-19 pandemic has transformed mobile health applications and telemedicine from nice to have tools into essential healthcare infrastructure. This need is particularly great for the elderly who, due to their greater risk for infection, may avoid medical facilities or be required to self-isolate. These are also the very groups at highest risk for cognitive decline. For example, during the COVID-19 pandemic artificially intelligent conversational agents were employed by hospitals and government agencies (such as the CDC) to field queries from patients about symptoms and treatments. Digital health tools also proved invaluable to provide neuropsychiatric and psychological self-help to people isolated at home or in retirement centers and nursing homes.

0 citations0 reviewsNo code linkedOpen access